RSV Insights: Genomic Evolution, Treatments, and Public Health Strategies
GenEpi-BioTrain — ECDC Virtual Training
10 – 13 December 2024
|
The aim of this virtual training is to provide participants with in-depth knowledge of RSV (Respiratory Syncytial Virus), including its genomic diversity, evolution, available treatments, and emerging vaccine strategies. The focus will be on how genomic data informs public health responses, the impact of RSV on vulnerable populations, and ongoing advancements in treatment and prevention. The training will also explore regulatory frameworks and public health strategies for managing RSV outbreaks.
The training is provided by Insitut Pasteur, France. If you are a microbiologist, epidemiologist or a bioinformatician interested in the biology, evolution and surveillance of RSV, please enrol today and tell your colleagues. It's open for public enrolment.
|
|
|
|
Note: If you missed any of the previous Virtual Trainings, you can watch the recorded sessions.
